Galectin Therapeutics Inc.

GALT·NASDAQ·$2.79Share Price as of 11/2·$184MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report08/14/26 8-KCurrent report08/04/26 8-KCurrent report06/23/26 8-KCurrent report05/15/26 8-KCurrent report03/31/26

Prospectuses and Registrations

S-3Shelf registration03/31/26 S-3Shelf registration04/14/23 S-8Registration of securities for employees03/30/23 S-8Registration of securities for employees11/09/20 S-3Shelf registration05/11/20

Proxies

DEF 14ADefinitive proxy10/13/26 DEFA14AAdditional proxy materials10/13/26 PRE 14APreliminary proxy10/02/26 DEF 14ADefinitive proxy10/22/25 DEFA14AAdditional proxy materials10/22/25

Ownership

Form 4Insider transaction08/04/26 SC 13D/ABeneficial ownership (amended)08/04/26 Form 4Insider transaction07/16/26 Form 4Insider transaction06/30/26 Form 4Insider transaction06/30/26

Other

ARSAnnual report to shareholders10/13/26 EFFECTRequest for effectiveness04/10/26 CORRESPCorrespondence with the SEC04/08/26 UPLOADLetter from the SEC04/06/26 ARSAnnual report to shareholders10/22/25